“…aging ( Acosta-Cabronero et al., 2016 ; Betts et al., 2016 ; Darki et al., 2016 ; Li et al., 2014 ; Persson et al., 2015 ), drug addiction ( Ersche et al., 2017 ), Alzheimer's disease ( Acosta-Cabronero et al., 2013 ; Ayton et al., 2017 ; Moon et al., 2016 ; van Bergen et al., 2016b ), Parkinson's disease ( Acosta-Cabronero et al., 2017 ; Guan et al., 2017 ; He et al., 2015 ), Huntington's disease ( Dominguez et al., 2016 ; van Bergen et al., 2016a ), neurodegeneration with brain iron accumulation ( Lobel et al., 2014 ), neuromuscular disease ( Acosta-Cabronero et al., In Press ; Costagli et al., 2016 ; Schweitzer et al., 2015 ), demyelinating disease ( Bian et al., 2016 ; Chen et al., 2014 ; Cronin et al., 2016 ; Li et al., 2016 ; Wisnieff et al., 2015 ; Zhang et al., 2016 ) and traumatic brain injury ( Liu et al., 2016 ). QSM has also been proposed for vascular monitoring both at single time points ( Fan et al., 2015 , 2016 ; Ozbay et al., 2015 ) or in combination with the MRI technique of arterial spin labelling to infer cerebral metabolic rates of oxygen extraction ( Buch et al., 2017 ; Zhang et al., 2018 ); and dynamically, using fast echo-planar acquisitions for functional MRI (fMRI) applications ( Balla et al., 2014 ; Bianciardi et al., 2014 ; Chen and Calhoun, 2015 ; Ozbay et al., 2016 ; Sun et al., 2017 ).…”